Avalo Therapeutics prices $375 million public offering at $17.75 per share May 5, 2026 11:34PM
Avalo Therapeutics Announces Pricing of $375 Million Public Offering May 5, 2026 11:33PM
Avalo Therapeutics announces public offering of stock and warrants May 5, 2026 04:05PM
Avalo Therapeutics Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants May 5, 2026 04:05PM
TD Cowen on Avalo Therapeutics (AVTX): 'Risk/Reward Skewed To Significant Upside For AVTX-009 Phase II' Feb 24, 2026 09:14AM


Feb 24, 2026 07:00AM Avalo Therapeutics to Participate in Upcoming Investor Conferences
Nov 3, 2025 07:00AM Avalo Therapeutics to Participate in Upcoming Investor Conferences
Sep 5, 2025 05:29AM TD Cowen Starts Avalo Therapeutics Inc. (AVTX) at Buy
Feb 24, 2025 07:00AM Avalo Therapeutics to Participate in Upcoming Investor Conferences